Patent · US Active

Modulating signal transduction pathways with substituted pyridol [2,3-b] pyrazines

US8536332B2 · kind B2 · utility

1Cited by

3References

25Claims

0Family size

Assignee

Aeterna Zentaris, Inc. · DE

Inventors

Matthias Gerlach · Wächtersbach, DE
Irene Seipelt · Offenbach, DE
Eckhard Guenther · Maintal, DE
Emmanuel Polymeropoulos · Frankfurt, DE
Tilmann Schuster · Großostheim, DE
Eckhard Claus · Frankfurt, DE

Key dates

Filing date	Apr 25, 2012
Grant date	Sep 17, 2013
Priority date	—
Expiry date	Apr 25, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Method of modulating ras-Raf-Mek-Erk signal transduction pathway, PI3K-Akt signal transduction pathway and/or SAPK signal transduction pathway with a pyrido[2,3-b]pyrazine of formula (Ia).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.